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Abstract
Background: Pulmonary alveolar proteinosis (PAP) is a rare disease, characterized by excessive intra-alveolar
accumulation of surfactant lipids and proteins. Therapeutic whole lung lavages are currently the principle
therapeutic option in adults. Not much is known on the kinetics of the wash out process, especially in children.
Methods:  In 4 pediatric and 6 adult PAP patients 45 therapeutic half lung lavages were investigated
retrospectively. Total protein, protein concentration and, in one child with a surfactant protein C mutation,
aberrant pro-SP-C protein, were determined during wash out.
Results: The removal of protein from the lungs followed an exponential decline and averaged for adult patients
2 – 20 g and <0.5 to 6 g for pediatric patients. The average protein concentration of consecutive portions was
the same in all patient groups, however was elevated in pediatric patients when expressed per body weight. The
amount of an aberrant pro-SP-C protein, which was present in one patient with a SP-C mutation, constantly
decreased with ongoing lavage. Measuring the optical density of the lavage fluid obtained allowed to monitor the
wash out process during the lavages at the bedside and to determine the termination of the lavage procedure at
normal protein concentration.
Conclusion: Following therapeutic half lung lavages by biochemical variables may help to estimate the degree of
alveolar filling with proteinaceous material and to improve the efficiency of the wash out, especially in children.
Introduction
Pulmonary alveolar proteinosis (PAP) is a rare respiratory
disease characterized by the accumulation of surfactant-
derived material in the lung of patients [1]. Currently PAP
is categorized into acquired, congenital, and secondary
PAP [2,3].
The acquired form of PAP is clinically characterized by
cough, dyspnea and progression to respiratory failure. The
presence of anti-GM-CSF auto-antibodies in serum and
bronchoalveolar lavage (BAL) is of diagnostic value for
this entity[3,4]. The congenital form of PAP is character-
ized by an acute onset immediately after birth with respi-
ratory distress and rapid progression[5]. Pathogenetically
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mutations of the genes encoding surfactant protein B [6,7]
and C[8,9], the GM-CSF receptor β subunit[10], or ABC-
A3 [11] may lead to the accumulation of proteinaceous
alveolar material. Secondary PAP is uncommon and
includes cases with lysinuric protein intolerance, acute
silicosis and other inhalational syndromes, immunodefi-
ciency disorders, and malignancies and hematopoietic
disorders[3].
Therapeutic bronchoalveolar lavages (BAL) are the princi-
ple option to reduce the abnormal accumulation of PAS
positive proteinaceous material that fills the alveolar
space of patients with pulmonary alveolar proteinosis
(PAP)[3]. Little is known about the kinetics of the protein
wash out during therapeutic whole lung lavages. The lav-
ages of one adult patient were investigated by Onodera et
al. and showed a rapid declining curve of protein and
phospholipid in the successive lavage fractions[12]. Doyle
et al. also showed the decrease of cholesterol, surfactant
protein A (SP-A), surfactant protein B (SP-B) and phos-
pholipids in aliquots[13]. Recently Perez and Rogers
reported in adult patients that chest percussion therapy
and positional changes during whole lung lavage
enhanced alveolar clearance[14]. In children almost no
data are available on the wash out kinetics.
The aim of the present study was to investigate the vol-
ume, the total amount, concentration and pattern of pro-
tein washed out of the lungs during such procedures in
pediatric and adult patients with PAP and in one patient
with cholesterol pneumonitis. The value of simple deter-
mination of the optical density (OD) to monitor the
progress of the lavage procedure and to help determine
when to stop the procedure was evaluated. We found an
exponential wash out of protein from the lungs and sug-
gest to lavage until the effluent has an OD at 405 nm of
0.04 or less, as this ensures that protein concentrations
present in the normal lung are achieved.
Patients and methods
A total of 45 lavages from patients with alveolar proteino-
sis were prospectively collected to study the wash out of
surfactant material from the lungs during therapeutic lung
lavage.
Pediatric patients with pulmonary alveolar proteinosis
PAP was diagnosed by the characteristic histologic pattern
of alveolar filling with periodic acidic Schiff positive mate-
rial in open lung biopsy in all children (patients J01, J02,
J03, J04). In addition the effluent from the lavages was
milky and showed the characteristic cytological pattern.
Patient J01 was described previously to have a hetero-
zygous SP-C mutation[9,15]. In the other children no SP-
B or SP-C mutations were detected. GMCSF autoantibod-
ies were negative in all these patients in serum and lavage.
Further clinical details of the subjects are given in Tab. 1.
Adult patients with pulmonary alveolar proteinosis
PAP was diagnosed by open lung biopsy (patients A01,
A02, A03) or by a combination of typical clinical and radi-
ological findings on HRCT and a diagnostic BAL showing
milky fluid and abundant extracellular periodic acidic
Schiff positive material on cytopreps (Patients A04, A05,
A06) [16]. Clinical details of the patients are given in Tab.
1. All 6 adults patients had idiopathic PAP with high titres
of GMCSF autoantibodies.
A child with cholesterol pneumonitis and suspected 
alveolar proteinosis (labeled as CHOL)
The diagnosis of idiopathic cholesterol pneumonitis,
associated with pulmonary alveolar proteinosis was made
by open lung biopsy and the child was referred to our cen-
tre for therapeutic lavage. He had progressive respiratory
distress and was oxygen dependent at that time. Two ther-
apeutic lavages were done, one on each side. However the
material obtained was not milky and thus the lavage pro-
cedure was terminated early, when almost clear fluid was
recovered.
Control children
Lavages from ten healthy children who participated in a
study on the biophysical activity of surfactant [17] were
used in this study as a comparison group. The children
had no history of chronic respiratory symptoms or recent
upper or lower respiratory tract infection. Their clinical
details are given in table 1. All children were undergoing
elective surgery for non pulmonary illnesses. Bronchoal-
veolar lavages (BAL) were performed during general
anaesthesia and tracheal intubation with an endhole cath-
eter wedged in the right lower lobe and the lavage was per-
formed as described below. The original study of these
children by BAL had been approved by the ethics commit-
tee (Nr. 97079) and written informed consent was given
[17]. For the present study those lavages were used to
determine the protein levels. The analysis of the therapeu-
tic lavages was done retrospectively on samples stored
after informed consent. The ethics committee had
approved the anonymous usage of these samples for fur-
ther variables of the surfactant system.
Bronchoalveolar lavages and processing of the lavage fluid
Initially, in each patient, a diagnostic bronchoalveolar lav-
age was done. This was done either through the endhole
catheter in the control children, through a bronchoscope
wedged in the adult PAP patients or in the pediatric
patients through a pulmonary artery catheter (Balloon
Wedge Pressure Catheter, 60 cm, inner diameter 6 French
= 2 mm, Arrow Inc., Reading, USA) in wedge-position on
the right or left side. Normal saline (0.9% NaCl) warmedR
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Table 1: Patient characteristics and overview on lavages performed
Patients Sex Body weight age at 
diagnosis
age at follow 
up
number of lavage 
sessions
number of 500 ml portions 
per lavage
total lavage volume 
recovered per lung
volume/b.w
(kg) (y) (y) left right left lung right lung (ml) (ml/kg)
PAP ped. (J01) m 8.5 1.75 5.8 9 11 9 (6.5/10) 6 (4/7) 3258 (2780/4080) 383.3
PAP ped. (J02) f 14.5 1.75 7.8 6 6 7.5 (5.5/10) 7 (5.5/9.5) 3353 (2862/3913) 231.2
PAP ped. (J03) f 4.5 0.33 died at age 1/3 1 1 2 8 270.3 60.1
PAP ped. (J04) m 4.3 0.08 died at age 1/4 1 1 2 4 1018.3 236.8
median (25/75 percentile) 6.5 (4.4/11.5)++ 1.0 (0.2/2.3)++ 2007 (644.3/3199) 234 (145.7/310)
PAP adult (A01) f 70.0 39.5 alive 1 1 28 29 14102 201.5
PAP adult (A02) f 69.6 39 alive 1 0 13 0 6608 94.4
PAP adult (A03) f 69.7 49 alive 0 1 0 35 17659 252.3
PAP adult (A04) f 70.2 37 alive 0 1 0 27 27000 385.7
PAP adult (A05)# m 80.5 51.5 alive 1 1 20 24 22000 275
PAP adult (A06)# m 80.1 43.5 alive 1 1 31 39 35000 437.5
median (25/75 percentile) 70.1 (69.7/80.3) 42 (38/50) 19830 (10355/31000)$$ 263.7 (248/411.6)$
Cholesterol – Pneumonitis (L01) m 13 6.5 13.5. LTX 1 1 n.a. 2 577.5 44.4
control (C01) f 13 1.5 n.a. 0 1 n.a. n.a. 12 0.9
control (C02) m 20 5 n.a. 0 1 n.a. n.a. 48 2.4
control (C03) m 16 4 n.a. 0 1 n.a. n.a. 23 1.4
control (C04) m 11 3 n.a. 0 1 n.a. n.a. 17 1.6
control (C05) f 11 2.5 n.a. 0 1 n.a. n.a. 21 1.9
control (C06) m 8.5 1.5 n.a. 1 0 n.a. n.a. 21 2.5
control (C07) f 7 0.5 n.a. 1 0 n.a. n.a. 12.5 1.8
control (C08) m 10 1.5 n.a. 1 0 n.a. n.a. 14 1.4
control (C09) m 11 2 n.a. 1 0 n.a. n.a. 17 1.6
control (C10) m 36 10.5 n.a. 1 0 n.a. n.a. 65 1.8
median (25/75 percentile) 11 (9.3/18) 2.3 (1.5/4.5) 19 (13.3/35) 1.7 (1.4/2.2)
n.a. = not applicable. b.w. = body weight. Only diagnostic bronchoalveolar lavage. i.e. 4 ml/kg in 4 fractions; LTX = lung transplantation; data are presented as median (25/75 percentile); y = years; 
# = every portion consists of 1000 ml, total protein of 500 ml portions calculated; BAL = bronchoalveolar lavage; f = female; m = male; All three groups (PAP ped, PAP adult and controls) were 
compared by Friedmann (ANOVA), followed by Dunn's post-hoc-test: +: p < 0.05, ++: p < 0.01, +++: p < 0.001 indicate differences between pediatric PAP and adult PAP. §: p < 0.05, §§: p < 0.01, 
§§§: p < 0.001 indicate differences between pediatric PAP and controls. $:p < 0.05, $$: p < 0.01, $$$: p < 0.001 indicate differences between adult PAP and controls.Respiratory Research 2005, 6:138 http://respiratory-research.com/content/6/1/138
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to body temperature (4 × 1 ml/kg body weight) was
instilled in aliquots of 1 ml/kg bw, in adults 160 ml (8
times 20 ml) were instilled and recovered with a 20 ml
syringe under manual control. The first aliquot of recov-
ered fluid was treated separately and 2–4 ml was used for
microbiological investigations. All consecutive aliquots
were pooled and labeled "BAL" throughout this paper.
The therapeutic lavages in the children were done with up
to 20 ml/kg b.w. aliquots of normal saline. In the small
infants where it was not possible to position a double
lumen endotracheal tube, a pulmonary artery catheter was
introduced through an endotracheal tube and wedged in
the main stem bronchus. The tightness of the fit of the bal-
loon was continuously monitored throughout the proce-
dure via a 1.8 or 2.3 mm flexible endoscope advanced
outside the tube and positioned proximal to the balloon
of the catheter. The fluid recovered was collected in con-
secutive 500 ml portions. In the adults, the therapeutic
lavages were done similarly through one port of a double
lumen endotracheal tube with 500–1000 ml aliquots of
normal saline, whereas the other port was used to venti-
late the contra lateral lung. The returned fluid was col-
lected in consecutive 1000 ml aliquots.
Analysis of proteins
Total protein concentration was measured by the method
of Bradford [18]. The abundance of an abberant proform
of SP-C, present in the lavages of subject J01 was deter-
mined by one dimensional SDS polyacrylamide gel elec-
trophoresis and western blotting[9,19].
For a rapid semi-quantitative assessment of the lavage
protein content, absorption measurements were per-
formed on the native lavage samples at a wave length of
405 nm. Spectra were obtained in a spectrophotometer
for wavelengths from 200 nm to 800 nm (Ultrospec 1000,
Amersham Pharmacia Biotech, Uppsala, Schweden).
Statistical analysis
Individual data points and where appropriate medians
with interquartile range and range are given. Two groups
were compared by Mann-Whitney test and several groups
by Kruskal Wallis Anova followed by Dunn post hoc test
for non-parametric variables. A p < 0.05 was considered
significant. Statistical analysis was performed with Prism
4.0 (Graph Pad Software, San Diego, USA).
Results
Therapeutic lavages were done in 4 children with median
age of 1 year at diagnosis of PAP, in 6 adults (median age
42 years) and in a 6.5 year old child with cholesterol
pneumonitis.
The recovered half lung lavage volume in adults was on
average about 20 l per lung and in infants 2 l per lung.
However, corrected for body weight, the same volume of
about 250 ml/kg b.w. was used for both groups (Tab. 1).
Recovery of instilled fluid in all therapeutic lavage proce-
dures was 100 ± 10 %.
The amount of protein removed from the lungs by the
therapeutic lavages varied substantially between subjects,
but not so much within a certain subject (J01 and J02 in
Fig. 1 and Tab. 2). For adult patients the removed amount
of protein varied between 2 – 20 g, while the removed
amount for pediatric patients was between < 0.5 to 6 g.
There were no significant differences between the right
and left lung (Fig. 1).
The average concentration of protein in the consecutive
portions of the half lung lavages was the same in adult,
pediatric patients and the patient with cholesterol pneu-
monitis. When expressed per kg – body weight, pediatric
patients had elevated concentrations (Tab. 2).
In the BAL, i.e. the diagnostic lavage, as defined in Meth-
ods, the concentrations of protein in adult and pediatric
patients were clearly elevated, compared to normal chil-
dren (Tab. 2). Corrected for kg – body weight, only the
pediatric patients had higher levels than the controls. This
difference was only about 3 – fold, too small to be reliable
for diagnostic purposes.
The kinetics of the wash out followed an exponential
decay function for all adult patients and for J01, J02, and
J04 (Fig. 2). In patient J03, due to an insufficient proce-
dure, because of instability of the patient, there was no
real wash out function visible. This patient had in addi-
tion a severe pulmonary infection, that led together with
the PAP to respiratory insufficiency and death within 8
weeks. The lavage in the child with the cholesterol pneu-
monitits was stopped at 1 liter due to very poor recovery
of proteinous material (Fig. 2), i.e. an almost clear efflu-
ent, suggesting that the histologically suggested alveolar
proteinosis was not of significant extent.
Using Western blot, clearly a wash out of an aberrant pro-
tein, i.e. pro SP-C, present in a child with PAP and SP-C
mutation[15], was demonstrated. As a constant amount
of protein was added to the gel, a continuous decrease of
this aberrant protein, with ongoing washout, which
affected all 3 aberrant pro SP-C bands equally, was
observed (Fig. 3).
An immediate estimate of the overall protein concentra-
tion would be very helpful for bed side monitoring of the
lavage procedure. There was a reasonable correlation
between direct OD readings, used to estimate the proteinR
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Table 2: Protein recovered from the lungs
Patients concentration of protein 
(µg/ml)
concentration of protein 
(µg/ml and kg body weight)
amount of protein 
(mg)
amount of protein 
(mg/kg body weight)
BAL half lung lavages BAL half lung lavages BAL half lung lavages BAL half lung lavages
PAP ped. (J01) 233 (195/285.1) 131 (107.5/163) 27.4 15.4 (12.6/19.2) 7.7 (7/10) 370 (287/405) 0.9 44 (34/48)
PAP ped. (J02) 306 (206.5/1149) 1010 (664/1199) 21.1 69.7 (45.8/82.7) 57 (39/134) 3214 (2262/4826) 3.9 222 (156/333)
PAP ped. (J03) 1034 2975 229.8 661 20.2 922 4.4 205
PAP ped. (J04) 352 269 81.9 62.6 5.1 223 1.2 52
median (25/75 percentile) 307 (207/1149) 236 (130/1010) 220 (147/252)§ 29.7 (16.4/127) 11.7 (8/42) 545.8 (347/2618) 3 (1/4) 68.7 (43.6/329.3)
PAP adult (A01) 1490 924 21.3 13.2 226.7 12828 3.24 186
PAP adult (A02) 322 274 4.60 3.9 54.1 1766 0.77 26
PAP adult (A03) 135 199 1.92 2.8 21.4 3488 0.31 50
PAP adult (A04) no data 569 no data 8.1 no data 15374 no data 220
PAP adult (A05)# no data 161.5 no data 2 no data 3563 no data 45
PAP adult (A06)# no data 1090 no data 13.6 no data 18820 no data 235
median (25/75 percentile) 846 (228/1491) 422 (180/1007) 4.6 5.8 (2.5/13.7)* 130 (38/227)$ 5650 (1034/16850)ns 0.8 77 (14.1/229.8)ns
Cholesterol-Pneumonitis (L01) 136.2 157 10.5 16.8 1.7 124 0.13 9.5
control (C01) 47 n.a. 3.58 n.a. 0.6 n.a. 0.05 n.a.
control (C02) 58 n.a. 2.88 n.a. 2.7 n.a. 0.14 n.a.
control (C03) 77 n.a. 4.82 n.a. 1.7 n.a. 0.11 n.a.
control (C04) 82 n.a. 7.41 n.a. 1.4 n.a. 0.13 n.a.
control (C05) 47 n.a. 4.30 n.a. 1.0 n.a. 0.09 n.a.
control (C06) 85 n.a. 9.96 n.a. 1.8 n.a. 0.21 n.a.
control (C07) 97 n.a. 13.90 n.a. 1.2 n.a. 0.17 n.a.
control (C08) 77 n.a. 7.71 n.a. 1.1 n.a. 0.11 n.a.
control (C09) 65 n.a. 5.92 n.a. 1.1 n.a. 0.10 n.a.
control (C10) 49 n.a. 1.36 n.a. 3.2 n.a. 0.09 n.a.
median (25/75 percentile) 71 (48.2/83) 5.4 (3.2/8.8) 1.3 (1/2.3)§§§§ 0.09
n.a. = not applicable. only diagnostic bronchoalveolar lavage. i.e. 4 ml/kg in 4 fractions; LTX = lung transplantation; data are presented as median (25/75 percentile); y = years; # = only every 
second portion available. total protein calculated; BAL = bronchoalveolar lavage; f = female; m = male. Two groups were compared by Mann-Whitney-test: ns: not significant,*: p < 0.05, **: p < 
0.01, ***: p < 0.001 indicate differences between pediatric and adult PAP All three groups (PAP ped, PAP adult and controls) were compared by Friedmann (ANOVA), followed by Dunn's post-
hoc-test: +: p < 0.05, ++: p < 0.01, +++: p < 0.001 indicate differences between pediatric PAP and adult PAP. §: p < 0.05, §§:p < 0.01, §§§: p < 0.001 indicate differences between pediatric PAP and 
controls. $: p < 0.05, $$: p < 0.01, $$$: p < 0.001 indicate differences between adult PAP and controlRespiratory Research 2005, 6:138 http://respiratory-research.com/content/6/1/138
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concentration from a previously made calibration curve
and the precise protein concentration, as assessed by a
colorimetric protein assay (Fig. 4a,b). There was consist-
ent agreement within thumb nail error (± 100 %) (Fig.
4c). Receiver operator curves calculated for different cut-
offs to stop the lavage procedure, showed a 100% specifi-
city (i.e. the fraction correctly defined as negative) with a
sensitivity (i.e. the fraction correctly defined as positive)
of at least 60% at the protein concentration found in
healthy subjects, i.e. 100 µg/ml or equivalent to an OD of
0.038 or less (Fig. 4b and 4d ).
Discussion
In this study we provide detailed data on the concentra-
tions, amounts and the wash out kinetics of proteins dur-
ing therapeutic half lung lavages in infants and adults
with PAP. A method was presented to easily monitor the
wash out process during lavages and to determine when a
physiological protein concentration is reached and a ther-
apeutic lavage procedure may be stopped.
Since their introduction by Ramirez[20], Wasserman [21]
and Seard [22], therapeutic lung lavages are the treatment
of choice in patients with PAP[3,14,23,24]. While this
procedures is well established and relatively easily per-
formed in adults, therapeutic lavages in children are tech-
nically much more challenging. There are 4 reports in
children[10,25-27], 7 in infants [5,28-33] and some in
neonates[26,30,34]. Therefore it is not yet clear if thera-
peutic lung lavages are effective in treating infants with
PAP. In addition there are almost no data on the protein
washed out in children. Here we present the first data on
such kinetics and on the amount of protein removed by
whole lung lavage in small children.
In adult patients about 80 – fold higher amounts of total
protein were recovered in comparison to normal whole
Amount of protein removed from the lungs of patients with pulmonary alveolar proteinosis of the adult (6 subjects, PAPadult), 4  children with PAP (J01 to J04), a child with idiopathic cholesterol pneumonitis, associated histologically with PAP (CHOL) and  in 10 control children (CON) Figure 1
Amount of protein removed from the lungs of patients with pulmonary alveolar proteinosis of the adult (6 subjects, PAPadult), 4 
children with PAP (J01 to J04), a child with idiopathic cholesterol pneumonitis, associated histologically with PAP (CHOL) and 
in 10 control children (CON). In the latter only regular diagnostic bronchoalveolar lavages were done. Each symbol represents 
the amount of protein recovered from a single lung lavage. L and R donates left and right sides. PAPadult represents total of 9 
half lung lavages from patients A01 to A06. Horizontal bars indicate medians.Respiratory Research 2005, 6:138 http://respiratory-research.com/content/6/1/138
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Protein concentrations in the diagnostic BAL and the consecutive 500 ml portions of lung lavages from patients with juvenile  PAP (J01 – J10), a patient with cholesterol pneumonitis and PAP (CHOL) and 3 adult patients with idiopathic PAP (A04 – A06) Figure 2
Protein concentrations in the diagnostic BAL and the consecutive 500 ml portions of lung lavages from patients with juvenile 
PAP (J01 – J10), a patient with cholesterol pneumonitis and PAP (CHOL) and 3 adult patients with idiopathic PAP (A04 – A06). 
Each symbol represents the protein concentration of one 500 ml portion lavage fluid recovered from one side. The numbers of 
BAL done on each side are indicated in Table 1. Horizontal bars indicate medians. Note the different scales of the protein axis.Respiratory Research 2005, 6:138 http://respiratory-research.com/content/6/1/138
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lung lavage values which were estimated by calculation
from rat lung washings[12]. Between 4 and 27.7 g were
obtained, values that were similar to the 1.8 to 22 g, we
found in this study. The control subjects in those studies,
i.e. patients with interstitial pneumonia or alveolar cell
carcinoma, had 2.8–3.4 g of protein recovered, which was
about 10-fold elevated compared to rat lung wash-
ings[12]. The amount of protein removed from children
with PAP was in the order of 0.4 g to 2.6 g (range 0.16 g
to 5.5 g). However, when expressed per kg body weight,
the same amount of protein was removed from the lungs
of children and adults.
A central problem in all studies on whole lung lavages is
the comparison group, as it is not appropriate to lavage
normal subjects or other patients without therapeutic
need. To circumvent this problem and to still be able to
compare controls and PAP lavages directly, we used the
regular diagnostic bronchoalveolar lavage (BAL) which
was done in all subjects, before the therapeutic lavages
were started, for comparison.
In our study we found protein concentrations in the diag-
nostic BAL that were increased 3 – fold in pediatric PAP
patients and 10 – fold in adult PAP patients in compari-
son to controls. Despite the significant difference to con-
trol values, the result is of limited use for diagnosing PAP.
There is substantial overlap with other lung diseases, like
pulmonary fibrosis [35], pneumonitis[36] and bronchial
asthma[37], where total protein may be elevated 2 – 5
fold, thus not allowing a clear diagnostic estimation. The
protein concentrations of therapeutic lavages performed
by others were 17 – 100 fold increased compared to
patients with chronic bronchitis, asthma and a patient
with interstitial fibrosis[38].
Until now, the protein wash out characteristic of the wash
out process of a therapeutic lavage has been reported for
only one patient[12]. For this reason the kinetics of the
wash out is of interest. Here, for adult subjects, we show
an exponential decay of protein during the procedures.
For children comparable results were obtained, however
at different levels of protein concentration (compare fig.
2, J01 and J02). The volumes used are about 1/10 of the
ones used in adults, but when corrected for kg body
weight, they were the same. A reasonable correlation
between the protein concentration determined by the
Bradford assay and the optical density of the lavage fluid
was demonstrated. Thus, the method to monitor the esti-
mated protein concentration in BAL fluids during lavage
was evaluated further. When an OD of 0.04 or less was
used as the cut off to stop the lavage procedure, the pro-
tein level was very likely to be less or in the range of the
maximum protein concentration observed in healthy sub-
jects.
Information on the progress of the wash out process from
simple online and bedside monitoring may be very help-
ful, as can also be demonstrated in the patient with cho-
lesterol pneumonitis. This subject had evidence from
histological pattern for both cholesterol pneumonitis and
PAP. The therapeutic lavage was stopped rather soon, as
the effluent appeared relatively clear by visual inspection.
However this may have been too early, because the pro-
tein concentration of the lavages determined after the pro-
cedure was finished, were always above 100 µg/ml. It has
previously been reported in an adult patient with endog-
enous lipoid pneumonia due to Niemann-Pick Type B,
that whole lung lavage may be successful with other diag-
noses than PAP [39].
Of interest was that aberrant pro SP-C protein not nor-
mally present in lavage and found in one patient with a
Western blot of 1 dimensional gel electrophoresis of BAL and 6 subsequent 500 ml portions of one lavage in patient J01 Figure 3
Western blot of 1 dimensional gel electrophoresis of BAL and 6 subsequent 500 ml portions of one lavage in patient J01. This 
patient was known to express an abberant pro-SP-C peptide in his lung. The blot was incubated with NPROSP-C Met10-Gln23 
as first and goat anti rabbit as secondary antibody to show 3 specific pro SP-C bands.Respiratory Research 2005, 6:138 http://respiratory-research.com/content/6/1/138
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SP-C mutation [9], steadily decreased during the ongoing
lavage, suggesting that this particular protein had accumu-
lated over time and was efficiently removed from the alve-
olar space without significant replacement during the
wash out.
In summary, there are considerable differences in the
amount of protein washed out by whole lung lavages in
children and adults with various forms of PAP. The
progress of therapeutic lavage procedures and the kinetics
of protein removed from the lungs during the lavage proc-
ess may be continuously estimated by simple OD meas-
urement of the effluent. This may help to make the lavage
procedure more efficient, especially in young children and
thus help to further optimize the technique in an age
group where the procedure is technically very demanding.
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